Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Nishikawa

Showing results (21-30 of 95) with videos related to

Pageof 10
Sort By:
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A Simulation Study of Light Propagation in the Spinal Cord for Optogenetic Surface StimulationShih-Yin Chang, Satoshi Nishikawa, Masaki Sekino, et al.
Biochemical and Biophysical Research Communications|November 16, 2004
An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activitiesKotaro Fukuda, Takuya Umehara, Satoru Sekiya, et al.
FEMS Yeast Research|February 4, 2009
Use of novel selenomethionine-resistant yeast to produce selenomethionyl protein suitable for structural analysisToshihiko Kitajima, Emi Yagi, Tomomi Kubota, et al.
Nucleic Acids Research|February 1, 2005
A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIIdKunio Kikuchi, Takuya Umehara, Kotaro Fukuda, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2011
An RNA aptamer containing two binding sites against the HCV minus-IRES domain IKeisuke Konno, Mana Iizuka, Syusuke Fujita, et al.
Nucleic Acids Symposium Series (2004)|September 9, 2008
Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain IKeisuke Konno, Syusuke Fujita, Mana Iizuka, et al.
Journal of Biochemistry|April 6, 2005
Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3Takuya Umehara, Kotaro Fukuda, Fumiko Nishikawa, et al.
Biochemical and Biophysical Research Communications|June 9, 2009
Increased inhibitory ability of conjugated RNA aptamers against the HCV IRESKunio Kikuchi, Takuya Umehara, Fumiko Nishikawa, et al.
DNA and Cell Biology|October 18, 2005
Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structureSatoyo Okahira, Fumiko Nishikawa, Satoshi Nishikawa, et al.
Nucleic Acids Research|March 26, 2003
Inhibition of HCV NS3 protease by RNA aptamers in cellsFumiko Nishikawa, Nobuko Kakiuchi, Kohei Funaji, et al.
Pageof 10

Showing results (21-30 of 95) with videos related to

Sort By:
Pageof 10
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 18, 2020
A Simulation Study of Light Propagation in the Spinal Cord for Optogenetic Surface StimulationShih-Yin Chang, Satoshi Nishikawa, Masaki Sekino, et al.
Biochemical and Biophysical Research Communications|November 16, 2004
An RNA ligand inhibits hepatitis C virus NS3 protease and helicase activitiesKotaro Fukuda, Takuya Umehara, Satoru Sekiya, et al.
FEMS Yeast Research|February 4, 2009
Use of novel selenomethionine-resistant yeast to produce selenomethionyl protein suitable for structural analysisToshihiko Kitajima, Emi Yagi, Tomomi Kubota, et al.
Nucleic Acids Research|February 1, 2005
A hepatitis C virus (HCV) internal ribosome entry site (IRES) domain III-IV-targeted aptamer inhibits translation by binding to an apical loop of domain IIIdKunio Kikuchi, Takuya Umehara, Kotaro Fukuda, et al.
Nucleosides, Nucleotides & Nucleic Acids|April 15, 2011
An RNA aptamer containing two binding sites against the HCV minus-IRES domain IKeisuke Konno, Mana Iizuka, Syusuke Fujita, et al.
Nucleic Acids Symposium Series (2004)|September 9, 2008
Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain IKeisuke Konno, Syusuke Fujita, Mana Iizuka, et al.
Journal of Biochemistry|April 6, 2005
Rational design of dual-functional aptamers that inhibit the protease and helicase activities of HCV NS3Takuya Umehara, Kotaro Fukuda, Fumiko Nishikawa, et al.
Biochemical and Biophysical Research Communications|June 9, 2009
Increased inhibitory ability of conjugated RNA aptamers against the HCV IRESKunio Kikuchi, Takuya Umehara, Fumiko Nishikawa, et al.
DNA and Cell Biology|October 18, 2005
Interferon-beta induction through toll-like receptor 3 depends on double-stranded RNA structureSatoyo Okahira, Fumiko Nishikawa, Satoshi Nishikawa, et al.
Nucleic Acids Research|March 26, 2003
Inhibition of HCV NS3 protease by RNA aptamers in cellsFumiko Nishikawa, Nobuko Kakiuchi, Kohei Funaji, et al.
Pageof 10